Trial Profile
Novel Assessment and Treatment Approaches for Detecting and Facilitating Functional Improvements in Post-Stroke Spasticity With Botulinum Toxin-A
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 May 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- 19 May 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 06 Feb 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 18 Jan 2013 New trial record